| Announce Date | 11/06/2025 |
| EPS Normalized Actual | $0.16 (Beat by $0.01) |
| EPS GAAP Actual | $0.16 (Beat by $0.01) |
| Revenue Actual | $0.139529B |
| Revenue Surprise | Beat by $139.529M |
| Announce Date | 03/28/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.1638 |
| EPS GAAP Estimate | $0.1638 |
| Revenue Estimate | $0.1309478B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 0 | INF | 0 | 0 | 0 |
| Dec 2026 | 0 | INF | 0 | 0 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.07 | 0.07 | 0.139529B | 1.33% | 139.53M |
| FQ2 2025 (Jun 2025) | 0.03 | 0.03 | 0.129405B | 1.51% | 129.41M |
| FQ1 2025 (Mar 2025) | -0.01 | -0.01 | 0.119066B | -4.31% | 119.07M |
| FQ4 2024 (Dec 2024) | -0.0483 | -0.0483 | 0.121572B | -6.93% | 121.57M |
| FQ3 2024 (Sep 2024) | -0.0445 | -0.0445 | 0.137667B | 16.41% | 137.67M |
| FQ2 2024 (Jun 2024) | -0.12 | -0.12 | 0.127447B | 12.9% | 127.45M |
| FQ1 2024 (Mar 2024) | -0.1 | -0.1 | 0.1242B | 100% | 124.2M |
| FQ4 2023 (Oct 2023) | -0.0119 | -0.0119 | 0.130003B | 8.83% | 130M |
FQ4 Announce Date
03/28/2026 (Pre-Market)
Consensus EPS Estimates
0.1638
Consensus Revenue Estimates
0.1309478B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.245 | -- | 0.23557 | 0.25401 | 1 |
| FQ3 2027 (Sep 2027) | 0.235 | -- | 0.22595 | 0.24365 | 1 |
| FQ2 2027 (Jun 2027) | 0.225 | -- | 0.21634 | 0.23328 | 1 |
| FQ1 2027 (Mar 2027) | 0.21 | -- | 0.20191 | 0.21773 | 1 |
| FQ4 2026 (Dec 2026) | 0.2116 | -- | 0.20345 | 0.21939 | 1 |
| FQ3 2026 (Sep 2026) | 0.2102 | 66.7 | 0.20211 | 0.21793 | 1 |
| FQ2 2026 (Jun 2026) | 0.2076 | 85.55 | 0.19961 | 0.21524 | 1 |
| FQ1 2026 (Mar 2026) | 0.1638 | 106.11 | 0.1008 | 0.2142 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.16B | -- | 0.16B | 0.17B | 2 |
| FQ3 2027 (Sep 2027) | 0.16B | -- | 0.15B | 0.16B | 2 |
| FQ2 2027 (Jun 2027) | 0.15B | -- | 0.15B | 0.15B | 2 |
| FQ1 2027 (Mar 2027) | 0.14B | -- | 0.14B | 0.15B | 2 |
| FQ4 2026 (Dec 2026) | 0.15B | -- | 0.15B | 0.15B | 2 |
| FQ3 2026 (Sep 2026) | 0.15B | 4.49 | 0.14B | 0.15B | 2 |
| FQ2 2026 (Jun 2026) | 0.14B | 4.99 | 0.13B | 0.14B | 2 |
| FQ1 2026 (Mar 2026) | 0.13B | 9.07 | 0.13B | 0.13B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.07 | 0.07 | 100% | |
| FQ2 2025 (Jun 2025) | 0.03 | 0.03 | 100% | |
| FQ1 2025 (Mar 2025) | -0.01 | -0.01 | 100% | |
| FQ4 2024 (Dec 2024) | -0.0483 | -0.0483 | 100% | |
| FQ3 2024 (Sep 2024) | -0.0445 | -0.0445 | 100% | |
| FQ2 2024 (Jun 2024) | -0.12 | -0.12 | 100% | |
| FQ1 2024 (Mar 2024) | -0.1 | -0.1 | 100% | |
| FQ4 2023 (Oct 2023) | -0.0119 | -0.0119 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.14B | $139.53M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.13B | $129.41M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.12B | $119.07M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.12B | $121.57M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.14B | $137.67M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.13B | $127.45M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.12B | $124.2M | 100% |
| FQ4 2023 (Oct 2023) | $0B | $0.13B | $130M | 100% |